Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,667 across all filing types
Latest filing 2010-06-30 Capital/Financing Update
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
BODOA options expiring 31 Dec 2011 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is a short announcement to the Australian Stock Exchange regarding the status of certain options (BODOA and BODAZ) and their expiry dates. It does not contain financial statements, detailed financial data, or management discussion. It is not a report but an update on capital instruments (options) and their issuance status. The document length is only 1289 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2010-06-30 English
Appendix 3B 8 pages ?Kb
Share Issue/Capital Change Classification · 95% confidence The document is an 'Appendix 3B - Allotment' announcement to the Australian Stock Exchange (ASX) dated 29 June 2010. It details the allotment of shares and options following the exercise of options, including the number of securities issued, their terms, issue price, and quotation details. Appendix 3B is a standard ASX form used for new issue announcements and applications for quotation of additional securities. The document is a regulatory announcement about share allotment and capital changes, not a financial report or management discussion. It does not contain financial statements or earnings data, nor is it a report or presentation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length (11,818 characters) is sufficient to be a full announcement, not just a brief notice. Hence, the classification is SHA with high confidence.
2010-06-28 English
Appendix 3B 8 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is an announcement to the Australian Stock Exchange regarding the allotment of shares following the exercise of options. It includes an Appendix 3B form, which is a standard ASX form used for new issue announcements and applications for quotation of additional securities. The content details the number and class of securities issued, exercise prices, dates, and other terms related to the share allotment and quotation. There are no financial statements, management discussion, or detailed financial results presented. The document is a regulatory announcement about a capital change event (share allotment and option exercise). Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief report publication announcement or a simple regulatory filing but a formal capital change announcement.
2010-05-30 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y – Change in Director’s Interest Notice' and references Listing Rule 3.19A.2 and section 205G of the Corporations Act, which are regulatory requirements for reporting changes in directors' shareholdings. The content details changes in securities holdings by a director, including number of securities before and after the change, nature of the change, and dates. This matches the definition of a Director's Dealing report, which involves personal share transactions by company directors and executives. The document is short and focused solely on this topic, with no financial statements or other report content. Therefore, the correct classification is Director's Dealing (DIRS).
2010-05-27 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'APPENDIX 3B - ALLOTMENT' and is an announcement to the Australian Stock Exchange regarding the allotment of shares following the exercise of options. It includes detailed information about the securities issued, their terms, issue price, purpose, and quotation application. Appendix 3B is a standard form used in Australian stock market filings to announce new issues of securities and their quotation on the exchange. The document is a regulatory announcement about a capital raising event (exercise of options and allotment of shares) rather than a full financial report or earnings release. It does not contain financial statements or management discussion but focuses on the issuance and quotation of new securities. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP). The document length (over 11,000 characters) and detailed content confirm it is not a brief notice or a report publication announcement but a substantive capital raising announcement.
2010-05-12 English
Appendix 3B 8 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is an announcement to the Australian Stock Exchange regarding the allotment of shares and options by bioMD Limited. It includes an Appendix 3B form, which is a standard ASX form used for new issue announcements and applications for quotation of additional securities. The content details the number and class of securities issued, terms of options, issue price, purpose, and quotation agreement. There are no financial statements, management discussion, or detailed financial analysis present. The document is a regulatory announcement about capital changes (share allotment and options issuance) rather than a full financial report or earnings release. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and detail support a high confidence in this classification.
2010-05-04 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.